The FDA is raising awareness about the risk of infections associated with reprocessed cystoscopes, ureteroscopes, and cystourethroscopes.

If your email program has trouble displaying this email, view as a webpage. Infections Associated with Reprocessed Urological Endoscopes - Letter to Health Care Providers Today, the U.S. Food and Drug Administration (FDA) wants to raise awareness among health care providers, including those working in reprocessing units in health care facilities, about the risk of infections associated with reprocessed urological endoscopes, including cystoscopes, ureteroscopes, and cystourethroscopes, used for viewing and accessing the urinary tract. The FDA has received numerous Medical Device Reports (MDRs) which describe patient infections post procedure or other possible contamination issues associated with reprocessing these devices. Read More The Letter to Health Care Providers includes important information about reprocessing methods including: Carefully following reprocessing methods according to the manufacturer's instructions. Recommendations for health care providers. Actions the FDA has taken to evaluate reports of infection and contamination associated with endoscopes and accessories used for accessing the urinary tract. Instructions for reporting problems with the devices. Questions? If you have questions, contact the Division of Industry and Consumer Education.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA